导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.22% | 787/1050 |
| 近一周 | -2.46% | 613/1104 |
| 近一月 | -8.92% | 982/1102 |
| 近一季 | 3.19% | 151/1092 |
| 近半年 | -5.56% | 634/1070 |
| 近一年 | -19.56% | 895/1018 |
| 近两年 | 66.70% | 379/926 |
| 近三年 | 48.08% | 264/834 |
| 成立以来 | 64.64% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.72% 703/1070 |
-4.47% 777/1101 |
- - |
- - |
| 2025 | 68.28% 67/1065 |
22.61% 16/1014 |
24.76% 12/1038 |
22.03% 537/1050 |
-9.85% 880/1065 |
| 2024 | -14.47% 844/1011 |
-8.41% 716/960 |
-10.52% 881/983 |
14.42% 265/991 |
-8.79% 862/1011 |
| 2023 | 10.62% 26/952 |
4.42% 356/880 |
-5.22% 539/895 |
1.42% 51/915 |
10.21% 2/952 |
| 2022 | -13.28% 139/867 |
-16.06% 312/773 |
7.38% 380/806 |
-10.04% 242/845 |
6.93% 138/867 |
| 2021 | -5.18% 417/740 |
- 151/580 |
13.91% 257/659 |
-12.14% 562/704 |
-5.25% 596/740 |
| 2020 | 101.56% 29/554 |
9.81% 45/419 |
39.01% 31/466 |
7.14% 318/517 |
23.24% 89/554 |
| 2019 | 46.91% 175/410 |
29.06% 425/1146 |
1.95% 171/1228 |
9.22% 123/390 |
2.23% 378/410 |
| 2018 | -22.65% 108/349 |
- - |
7.23% 10/990 |
-13.48% 920/1000 |
-18.92% 981/1080 |
| 2017 | 8.65% 141/285 |
- - |
- - |
- - |
- - |
| 2016 | -20.25% 118/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 鹏华医药科技股票A VS. 东吴新产业精选股票A(580008) |